Use of mesenchymal stem cells in treating osteoarthritis
Abstract:
The present invention relates to a use of hypoxia-cultured mesenchymal stem cells (MSCs) for manufacture of a cell graft for treating a musculoskeletal disorder, particularly osteoarthritis.
Public/Granted literature
Information query
Patent Agency Ranking
0/0